| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 15.561.157 | 32.093.162 | 36.213.901 | 47.005.371 | 46.030.366 |
| Total Income - EUR | - | - | - | - | 0 | 15.571.907 | 32.133.282 | 36.266.691 | 47.123.814 | 46.185.757 |
| Total Expenses - EUR | - | - | - | - | 8.404 | 15.220.127 | 31.238.126 | 35.057.661 | 45.665.790 | 44.767.881 |
| Gross Profit/Loss - EUR | - | - | - | - | -8.404 | 351.781 | 895.156 | 1.209.030 | 1.458.023 | 1.417.876 |
| Net Profit/Loss - EUR | - | - | - | - | -8.404 | 297.828 | 781.173 | 1.053.979 | 1.285.370 | 1.213.213 |
| Employees | - | - | - | - | 1 | 36 | 35 | 37 | 43 | 47 |
Check the financial reports for the company - Maxifarma Healthcare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 14.922 | 170.912 | 176.037 | 267.734 | 314.582 |
| Current Assets | - | - | - | - | 6.079 | 10.646.180 | 12.233.205 | 13.263.060 | 17.118.970 | 12.504.815 |
| Inventories | - | - | - | - | 0 | 5.188.094 | 5.177.453 | 5.581.118 | 7.554.303 | 6.973.862 |
| Receivables | - | - | - | - | 0 | 5.432.991 | 6.951.413 | 7.662.039 | 9.503.838 | 5.462.515 |
| Cash | - | - | - | - | 6.079 | 25.095 | 104.339 | 19.903 | 60.828 | 68.438 |
| Shareholders Funds | - | - | - | - | -8.362 | 298.928 | 1.066.024 | 1.180.926 | 2.462.715 | 1.802.606 |
| Social Capital | - | - | - | - | 42 | 9.344 | 9.137 | 9.166 | 9.138 | 9.087 |
| Debts | - | - | - | - | 14.441 | 10.362.335 | 11.338.823 | 12.261.348 | 14.936.529 | 11.031.272 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Maxifarma Healthcare S.r.l.